What is the ELVN stock price prediction for next 2 weeks?

According to our price prediction algorithm,Enliven Therapeutics, Inc. (ELVN) price will be around $35.40 in the next 2 weeks. This means it will decrease by -10.57236675928265 from the last closing price. This prediction may vary from other time period filters for ELVN stock.

What can be the highest Possible price of ELVN stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, ELVN can achieve the highest price of $37.46 which is -5.372328520098009 lower than last closing price. This prediction may vary from other time period filters for ELVN stock.

What can be the lowest Possible price of ELVN stock in next 2 weeks?

As per the forecast and algorithmic analysis, ELVN stock price can be as low as $33.27 which is -15.956582946211908 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for ELVN stock.

Will ELVN stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that ELVN stock will lose-10.57236675928265 in the next 2 weeks. This prediction may vary from other time period filters for ELVN stock.

What is ELVN stock last closing price?

Last closing price of ELVN stock was $39.59.

What is ELVN stock price prediction?

ELVN stock price prediction means predicting the future closing prices of ELVN stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of ELVN stock in a certain time period.

How we predict ELVN stock future prices?

If you are searching for ELVN stock forecast, analysis or price prediction, then you might be wondering what Enliven Therapeutics, Inc. (ELVN) will do in the future. Our ELVN price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This ELVN price prediction will likely answer most of your questions.

How frequent we update ELVN stock predictions?

We are updating the forecasts for the ELVN stock on daily basis.

Is using ML forecasting for ELVN stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for ELVN stock same for all the time periods?

No, the prediction for ELVN stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Enliven Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$39.59-7.89%Since 2 Weeks

Predicted Price$35.40-10.57%For 2 Weeks

Upper Predicted Price$37.46-5.37%For 2 Weeks

Lower Predicted Price$33.27-15.96%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of ELVN will decline by -10.57% over the next 2 Weeks and hit $35.40 by Monday, May 25, 2026. In that time frame, ELVN's share price is expected to range between $33.27 and $37.46.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
May 25, 2026	33.27	35.40	37.46
May 22, 2026	36.14	38.14	40.22
May 21, 2026	34.76	36.65	38.65
May 20, 2026	35.07	36.79	38.43
May 19, 2026	35.84	37.34	39.02
May 18, 2026	35.41	37.10	38.73
May 15, 2026	38.42	39.84	41.38
May 14, 2026	36.86	38.35	39.86
May 13, 2026	36.98	38.49	40.11
May 12, 2026	37.59	39.04	40.58

ELVN shares rose +5.86% in Tuesday, May 12, 2026's trading session, rising from a previous close of $39.59 to move at $41.91. The stock demonstrated notable intraday movement (see ELVN's key stats for a full breakdown), fluctuating between $40.01 and $43.28, a +8.17% trading range. While recent weeks have seen some volatility, ELVN has managed to secure a -6.66% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 693.44K shares changing hands, 109.62K more than the previous session. This amounted to $29.06M in total market activity.

Will ELVN Continue Its Downward Trend?

According to analyst ratings and projections for ELVN, Enliven Therapeutics, Inc. shares are anticipated to decrease by -11.87%, potentially reaching $37.46 per share by May 25, 2026. Short-term technical indicators currently suggest a neutral sentiment for ELVN. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the ELVN stock forecast, now is not the best time to buy ELVN stock because its current trading price is +18.38% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ELVN covering social and institutional perspectives.

ELVN Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into ELVN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 50.91% to 55.18%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 58.41%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 57.48%, maintains a neutral outlook for the long term. Insights into ELVN's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Enliven Therapeutics Short-Term Forecasts

ELVN Forecast For Next 5 Days

Our algorithm anticipates Enliven Therapeutics (ELVN) stock could hit $37.74 by May 19, 2026. This represents a -9.96% rise from today's price, following a +8.07% change over the past five days.

ELVN Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Enliven Therapeutics, Inc. (ELVN) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $43.00, which would mean a +2.60% increase from the current price of $41.91. Projections for this period range from a high of $51.70 to a low of $32.51.

ELVN Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Enliven Therapeutics's price over the next three months point to a drop. ELVN stock is expected to peak at $44.82 on Jun 16, 2026 after potentially dipping to $36.84 on May 15, 2026. On average, ELVN is likely to trade around $41.04 in the coming 90 days.

Enliven Therapeutics Stock Forecast 2025

Based on our predictive models, Enliven Therapeutics (ELVN) is expected to trade between $36.84 and $46.33 throughout 2026. This would result in an average price of $41.84, potentially offering investors a -0.17% return from current levels.

Enliven Therapeutics, Inc. Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, Enliven Therapeutics, Inc. (ELVN) is positioned to show a strong performance in May 2026. The price is predicted to move between $36.84 and $41.57, settling at an average of $39.26. This could translate to a -6.32% loss.

June 2026

Based on current market signals, Enliven Therapeutics, Inc. is projected to trend june 2026. We forecast a trading range from $37.80 to $44.82, with a likely average price of $41.71. Investors could expect a potential return of -0.48%.

July 2026

Our predictive algorithms indicate Enliven Therapeutics, Inc. stock may see a shift in July 2026. The expected range spans $38.84–$43.81, with an average target of $41.34. This represents a cautious outlook and a possible loss of -1.36%.

August 2026

Analyzing established trends, Enliven Therapeutics, Inc. looks set to move in August 2026. Projections place the stock between $38.98 and $44.00, averaging around $41.57. This suggests a -0.81% loss from current levels.

September 2026

Market indicators suggest Enliven Therapeutics, Inc. could experience notable changes during September 2026. Prices could fluctuate within $39.89 to $45.90, with a midpoint forecast of $43.11. The stock might deliver a +2.86% gain.

October 2026

Forecasting for October 2026, models estimate that Enliven Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $37.80 and $44.89, averaging $40.97. This signals a cautious trajectory with potential returns around -2.24%.

November 2026

According to our latest forecast models, Enliven Therapeutics, Inc. (ELVN) is positioned to show a strong performance in November 2026. The price is predicted to move between $40.02 and $46.33, settling at an average of $43.25. This could translate to a +3.20% gain.

December 2026

Based on current market signals, Enliven Therapeutics, Inc. is projected to trend december 2026. We forecast a trading range from $40.20 to $45.11, with a likely average price of $42.65. Investors could expect a potential return of +1.77%.

January 2027

Our predictive algorithms indicate Enliven Therapeutics, Inc. stock may see a shift in January 2027. The expected range spans $40.48–$45.46, with an average target of $42.88. This represents a positive outlook and a possible gain of +2.31%.

February 2027

Analyzing established trends, Enliven Therapeutics, Inc. looks set to move in February 2027. Projections place the stock between $41.39 and $47.09, averaging around $44.52. This suggests a +6.23% gain from current levels.

March 2027

Market indicators suggest Enliven Therapeutics, Inc. could experience notable changes during March 2027. Prices could fluctuate within $39.34 to $46.03, with a midpoint forecast of $42.32. The stock might deliver a +0.98% gain.

April 2027

Forecasting for April 2027, models estimate that Enliven Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $41.37 and $47.38, averaging $44.52. This signals a positive trajectory with potential returns around +6.23%.

May 2027

According to our latest forecast models, Enliven Therapeutics, Inc. (ELVN) is positioned to show a strong performance in May 2027. The price is predicted to move between $41.79 and $45.95, settling at an average of $43.95. This could translate to a +4.87% gain.

ELVN's history of dividends and stock splits also plays a role in long-term investor confidence.